While you may start with a certain regimen, you may not sick to it. Here are 7 signs that your asthma medication isn't ...

Montelukast, an asthma drug, can bind to and block a crucial SARS-CoV-2 protein. This discovery sets the stage for a new class of antiviral drugs, designed to target and interfere with the virus ...

Fact checked by Nick Blackmer About the Author Patricia Mikula, PharmD, has over nine years of experience and works as an inpatient clinical pharmacist for medical/surgical and intensive care unit ...

Popular asthma drug Singulair could be linked to mental health side effects, suicides: FDA The medication is "definitely doing something that's concerning," said Julia Marschallinger, a scientist ...

One study found three extra adverse events - mostly hospitalizations - for every thousand patients who took a LABA-containing drug compared to another asthma medication, said FDA's Dr. Gerald Dal Pan.

The price of asthma medication has increased significantly since 2008, when the FDA banned CFC inhalers for environmental reasons. The price of inhalers jumped from $10 to more than $100 in some ...

In early 2020, the Food and Drug Administration responded to decades of escalating concerns about a commonly prescribed drug for asthma and allergies by deploying one of its most potent tools: ...

Asthma drug can help reduce allergic reactions for those with severe food allergies The FDA approved the drug Xolair earlier this month, making it the first medication approved to reduce allergic ...

After two popular asthma drugs were discontinued this month, some physicians are concerned that patients could be left scrambling for alternatives and face higher refill costs for its generic ...

Government health advisers recommended restrictions Thursday on some long-acting asthma drugs, although not Advair, a top-selling medication. Outside experts advising the Food and Drug ...

Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at $35 per month, a move that offers relief but doesn't fully address the larger issue of high drug ...